Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel Monotherapy in Adults With Focal Seizures (Observational Cohort, Nanjing Brain Hospital)
ChiCTR2300074575Phase 4Completed
- Sponsor
- Affiliated Brain Hospital of Nanjing Medical University
- Start
- Nov 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of perampanel in epilepsy, sponsored by Affiliated Brain Hospital of Nanjing Medical University. Primary endpoint: Seizure freedom rate at 12 months. Started Nov 2021; status: completed.
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR2300074575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074575.